Tarlatamab approved to treat adult patients with small cell lung cancer 

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 31 December 2024, approved the medicine tarlatamab (Imdyllytra) to treat adult patients with small cell lung cancer (SCLC) that has spread throughout …